KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Receivables (2016 - 2026)

Emergent BioSolutions has reported Receivables over the past 17 years, most recently at $139.9 million for Q1 2026.

  • For Q1 2026, Receivables fell 31.72% year-over-year to $139.9 million; the TTM value through Mar 2026 reached $139.9 million, down 31.72%, while the annual FY2025 figure was $102.4 million, 41.18% down from the prior year.
  • Receivables for Q1 2026 was $139.9 million at Emergent BioSolutions, up from $102.4 million in the prior quarter.
  • Over five years, Receivables peaked at $341.9 million in Q2 2023 and troughed at $102.4 million in Q4 2025.
  • A 5-year average of $211.3 million and a median of $216.4 million in 2022 define the central range for Receivables.
  • Biggest five-year swings in Receivables: soared 48.59% in 2023 and later crashed 63.16% in 2025.
  • Year by year, Receivables stood at $216.4 million in 2022, then rose by 12.01% to $242.4 million in 2023, then dropped by 28.18% to $174.1 million in 2024, then tumbled by 41.18% to $102.4 million in 2025, then soared by 36.62% to $139.9 million in 2026.
  • Business Quant data shows Receivables for EBS at $139.9 million in Q1 2026, $102.4 million in Q4 2025, and $168.8 million in Q3 2025.